Boston Scientific (BSX) Shares Fall 3.5% Due to Cyberattack
Published on · Source: cnbc.com
AI Summary
Summarized by AI from the source belowBoston Scientific (BSX) reported a cyberattack this week disrupting its operations and access to information systems, according to an SEC filing. The attack led to a 3.5% decline in premarket trading. Additionally, shares of the $72 billion medical device maker have nearly halved this year following a weak profit forecast from the first quarter. The company is working to restore affected systems, but a timeline for full restoration remains unclear, impacting investor confidence.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About Boston Scientific Corporation (BSX)
Boston Scientific makes medical devices for cardiology and other specialties.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
Earlier BSX news
- Boston Scientific stock down 0.4% on market changes
- Boston Scientific (BSX) reports $5.4B Q2 revenue with 7.5% growth
- Boston Scientific (BSX) Price Target Cut to $64 by Truist
- Boston Scientific (BSX) Price Target Cut by Jefferies on Growth Outlook
- Boston Scientific Reports Clinical Trials Driving Growth in Cardiology Market
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
